Phase 4 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with stable coronary artery disease (a long-term heart condition affecting the blood vessels of the heart) who are scheduled for a planned procedure to open a blockage in a natural coronary artery that has not been treated before.
Who may not be able to join:
- People who have taken a type of diabetes medication called an SGLT-2 inhibitor at any point in the last month.
- People who are currently taking any medication that reduces inflammation, such as steroids, immunosuppressants, or common pain relievers like ibuprofen or naproxen.
- People who have an ongoing condition that causes inflammation in the body, such as rheumatoid arthritis, an active infection, or an active cancer.
- People who have had a heart attack or serious heart event in the last month.
- People whose procedure involves re-treating a previously treated blockage, or treating a blockage in a bypass graft (a replacement blood vessel used in a prior heart surgery).
- People whose kidneys are not working well enough, based on a specific kidney function measurement falling below a certain level (confirm with trial site).
- People whose procedure requires specialised devices beyond standard balloons and stents, such as tools used to break up very hard blockages (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rabih R Azar, MD, MPH, Hotel Dieu de Frace
Phone: +9613590999
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CRP change
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.